What Drove Elevra Lithium's (ASX:ELV) Record Production Quarter at North American Lithium?

Sonal Goyal

03 November 2026 11:57 PM AEDT

What Drove Elevra Lithium's (ASX:ELV) Record Production Quarter at North American Lithium?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

North American Lithium mined a record 466,499 wet metric tonnes of ore in Q1 FY27, a 25% increase quarter-on-quarter, while the mill processed 364,987 dmt, the first quarter in NAL history above 360,000 dmt.
Spodumene concentrate production of 54,907 dmt at 5.1% grade was the second-best quarter on record, generating Revenue of US$74 million at an average realised price of US$1,276/dmt (US$1,524/dmt SC6 equivalent).
Unit operating costs fell 14% quarter-on-quarter to US$780/dmt sold, delivering an operating cash Margin of US$476/dmt and reflecting higher sales volumes and operational efficiency.
Subsequent to quarter end, Elevra executed a binding Supply agreement with LG Energy Solution for 240,000 dmt of spodumene concentrate and completed the US$71 million sale of the Ewoyaa Project to Huayou Cobalt.

Elevra Lithium Limited (ASX:ELV; NASDAQ:ELVR) reported its strongest Mining quarter to date at North American Lithium (NAL) in the September 2026 quarter, the first quarter of FY27. Ore mined reached a record 466,499 wet metric tonnes, a 25% increase from the 372,938 wmt recorded in the June 2026 quarter, driven by mining activity progressing into areas hosting thicker veins, including the Marvelous zone.

Total material mined increased 12% quarter-on-quarter, while the strip ratio declined as the operation benefited from thicker ore zones. The mill processed 364,987 dmt of ore for the quarter, up 2% quarter-on-quarter and marking the first time in NAL's history that more than 360,000 dmt of ore was processed in a single quarter. Mill utilisation was maintained at 91%, the third consecutive quarter above 90%, despite a major planned concentrator shutdown reducing availability in the second half of the quarter.

Production and Sales Performance

Spodumene concentrate production reached 54,907 dmt at an average grade of 5.1% for the quarter, the second-highest quarter on record, with lithium recoveries of 70% consistent with the prior quarter. The feed grade of ore delivered to the run-of-mine stockpile improved to 1.08% Li2O from 1.06% Li2O in the June quarter, reflecting improved ore sorting performance at the ROM pad and in the crushing circuit.

Spodumene concentrate sales of 58,134 dmt were significantly higher than the prior quarter's 33,977 dmt, with two cargoes sold during the period. Revenue of US$74 million represents a 137% increase quarter-on-quarter, driven by the 71% increase in tonnes sold and a 39% increase in the average realised selling price to US$1,276/dmt FOB (US$1,524/dmt SC6 equivalent). The FOB price was estimated with reference to Spot Price indices at 30 September 2026, with final pricing to settle in the December quarter.

Unit Cost Reduction and Margin Expansion

Unit operating costs of US$780/dmt sold represent a 14% reduction from US$907/dmt in the prior quarter, reflecting the benefits of higher sales volumes against a largely Fixed Cost base. The operating cash margin of US$476/dmt sold illustrates NAL's competitiveness at current pricing levels. Capital Expenditure of US$9 million in the quarter was allocated to sustaining capital and the NAL Expansion project, which moved from planning to execution during Q1 FY27 with detailed engineering, long-lead item procurement, installation and demolition activities commencing.

Strategic Corporate Activity

Several significant corporate developments were announced during and immediately after the quarter. Shareholders approved all five resolutions at the Extraordinary General Meeting on 16 July 2026, including issuance of the upfront Tranche of convertible notes to the Canada Growth Fund (CGF). US$46 million of convertible notes were subsequently issued to CGF. Subsequent to the quarter end, Elevra executed a binding spodumene supply agreement with LG Energy Solution for 240,000 dmt, priced on a market basis. The Ewoyaa Project was sold to Zhejiang Huayou Cobalt Co., Ltd. for approximately US$71 million in cash on 26 October 2026, sharpening Elevra's portfolio focus on North America.

Balance Sheet and Liquidity

Cash at 30 September 2026 was US$319 million, up US$63 million from June 2026, reflecting the Canada Growth Fund convertible note proceeds and cash generated from operations. Net cash was US$240 million after the US$46 million convertible note Facility and US$33 million prepayment facility. The Ewoyaa sale proceeds of approximately US$71 million received subsequent to quarter end are not included in this balance, providing additional Liquidity as the NAL Expansion advances. The NAL Expansion is described by management as fully funded at current cash levels.

Sector Context

The lithium market experienced price Volatility during the September quarter, with spodumene prices rallying in August before easing through September and into October. Despite this, spodumene markets remained physically tight, with consecutive record monthly Chinese spodumene imports in August and September 2026. Management views recent price movements as a normal fluctuation in a developing market underpinned by structural Demand from electric vehicle penetration and energy storage system growth.

Risks

Safety performance during the quarter did not meet management expectations, with six recordable injuries — predominantly musculoskeletal — contributing to a higher total recordable injury frequency rate. No common causal Factor was identified. NAL is responding through strengthened coaching, visible field Leadership and consistent application of critical risk controls. The finalisation of pricing for the two September quarter cargoes in the December quarter introduces Earnings uncertainty at the margin. Expansion project execution risk, lithium price volatility and the path to converting the LG Energy Solution supply agreement from conditional to unconditional are ongoing considerations.

What to Watch Next

The finalisation of September quarter cargo pricing in the December quarter, early results from the NAL Expansion project, and any update on Mangrove Lithium securing financing for its conversion facility — the key condition precedent to the Mangrove supply agreement becoming unconditional — will be closely monitored. Progress on the Moblan scoping study and the Carolina Lithium permitting process will be the primary development project catalysts.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.